Insights on virulence and antibiotic resistance: A review of the accessory genome of Staphylococcus aureus

Wounds

Volumn 19, Issue 9, 2007, Pages

  Shittu, Adebayo O ^a   Udo, Edet E ^b   Lin, Johnson ^b  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^b NONE

Author keywords

Autolytic debridement; Compression stockings; Delayed wound healing; Diabetic foot wounds; Impaired wound healing; Mechanical debridement; Pressure dressing; Surgical debridement; Wound fibroblasts; Wound necrosis

Indexed keywords

EID: 34948894899     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Ogston A. Micrococcus poisoning. J Anat Physiol. 1882;17(1):24-58.
2. Kluytmans J, van Belkum A,Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505-520.
3. Gong JQ, Lin L, Lin T, et al. Skin colonization of Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006;155(4):680-687.
4. Peacock JE Jr, Marsik FJ,Wenzel RP. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med. 1980;93(4):526-532.
5. Toshkova K, Annemuller C,Akineden O, Lammler C. The significance of nasal carriage of Staphylococcus aureus as risk factor for human skin infections. FEMS Microbiol Lett. 2001;202(1):17-24.
6. Tenover FC, Gaynes RP. The epidemiology of Staphylococcus infections. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI, eds. Gram-positive Pathogens. Washington, DC: American Society for Microbiology; 2000:414-421.
7. Ladhani S, Garbash M. Staphylococcal skin infections in children: rational drug therapy recommendations. Paediatr Drugs. 2005;7(2):77-102.
8. Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care. 2006;10(3):R97.
9. Tacconelli E, Pop-Vicas AE, D'Agata EM. Increased mortality among elderly patients with methicillin -resistant Staphylococcus aureus bacteraemia. J Hosp Infect. 2006;64(3):251-256.
10. Kaplan SL,Versalovic J, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005;40(12):1785-1791.
11. Seybold U, Kourbatova EV, Johnson JG, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis. 2006;42(5):647-656.
12. Roberts SM, Freeman AF, Harrington SM, Holland SM, Murray PR, Zelazny AM. Linezolid-resistant Staphylococcus aureus in two pediatric patients receiving low-dose linezolid therapy. Pediatr Infect Dis J. 2006;25(6):562-564.
13. Gales AC, Sader HS, Andrade SS, Lutz L, Machado A, Barth AL. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis. Int J Antimicrob Agents. 2006;27(4):300-302.
14. Mangili A, Bica I, Snydman DR, Hamer DH. Daptomycinresistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2005;40(7):1058-1060.
15. Marty FM,Yeh WW, Wennersten CB, et al. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J Clin Microbiol. 2006;44(2):595-597.
16. Holden MT,Feil EJ, Lindsay JA, et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A. 2004;101(26):9786-9791.
17. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov. 2007;6(1):29-40.
18. Kuroda M, Ohta T, Uchiyama I, et al. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet. 2001;357 (9264):1225-1240.
19. Baba T,Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002;359(9320):1819-1827.
20. Gill SR,Fouts DE, Archer GL, et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol. 2005;187(7):2426-2438.
21. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community acquired methicillin-resistant Staphylococcus aureus. Lancet. 2006;367 (9512):731-739.
22. Roe B,Tian Y, Jia H, et al. Staphylococcus aureus Genome Sequencing Project. Staphylococcus aureus NCTC 8325 genome sequencing. Available at: www.genome.ou.edu/staph.html. Accessed: April 15, 2005.
23. Lindsay JA, Holden MT. Staphylococcus aureus: superbug, super genome? Trends Microbiol. 2004;12(8):378-385.
24. Lindsay JA, Holden MTG. Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus. Funct Integr Genomics. 2006;6(3):186-201.
25. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton- Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359(9308):753-759.
26. Williams RJ,Ward JM, Henderson B, et al. Identification of a novel gene cluster encoding staphylococcal exotoxinlike proteins: characterization of the prototypic gene and its protein product, SET1. Infect Immun. 2000;68(8):4407-4415.
27. Hiramatsu K, Watanabe S,Takeuchi F, Ito T, Baba T. Genetic characterization of methicillin-resistant Staphylococcus aureus. Vaccine. 2004;22(Suppl 1):S5-S8.
28. Lindsay JA, Ruzin A, Ross HF, Kurepina N, Novick RP.The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol Microbiol. 1998;29(2):527-543.
29. Hiramatsu K, Cui L, Kuroda M, Ito T.The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2001;(10):486-493.
30. Ito T, Okuma K, Ma XX,Yuzawa H, Hiramatsu K. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Updat. 2003;6(1):41-52.
31. Katayama Y, Ito T, Hiramatsu K.A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2000;44(6):1549-1555.
32. Ito T, Katayama Y, Asada K, et al. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2001;45 (5):1323-1336.
33. Hiramatsu K, Katayama Y, Yuzawa H, Ito T. Molecular genetics of methicillin-resistant Staphylococcus aureus. Int J Med Microbiol. 2002;292(2):67-74.
34. Ma XX, Ito T, Tiensasitorn C, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillinresistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 2002;46(4):1147-1152.
35. Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother. 2004;48(7):2637-2651.
36. Ito T, Katayama Y, Hiramatsu K. Cloning and nucleotide sequence determination of the entire mec DNA of premethicillin- resistant Staphylococcus aureus N315. Antimicrob Agents Chemother. 1999;43(6):1449-1458.
37. Hanssen AM, Ericson Sollid JU. SCCmec in staphylococci: genes on the move. FEMS Immunol Med Microbiol. 2006;46(1):8-20.
38. Katayama Y, Takeuchi F, Ito T, et al. Identification in methicillin- susceptible Staphylococcus hominis of an active primordial mobile genetic element for the staphylococcal cassette chromosome mec of methicillin-resistant Staphylococcus aureus. J Bacteriol. 2003;185(9):2711-2722.
39. O'Brien FG, Price C, Grubb WB, Gustafson JE. Genetic characterization of the fusidic acid and cadmium resistance determinants of Staphylococcus aureus plasmid pUB101. J Antimicrob Chemother. 2002;50(3):313-321.
40. Goering RV, McDougal LK, Fosheim GE, Bonnstetter KK, Wolter DJ,Tenover FC. Epidemiologic distribution of the arginine catabolic mobile element among selected methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates. J Clin Microbiol. 2007;45(6):1981-1984.
41. Zhang S, Iandolo J, Stewart GC. The enterotoxin D plasmid of Staphylococcus aureus encodes a second enterotoxin determinant (sej). FEMS Microbiol Lett. 1998;168(2):227-233.
42. Yamaguchi T, Hayashi T, Takami H, et al. Complete nucleotide sequence of a Staphylococcus aureus exfoliative toxin B plasmid and identification of a novel ADPribosyltransferase, EDIN-C. Infect Immun. 2001;69(12):7760-7771.
43. Murphy E. Transposable elements in gram-positive bacteria. In: Berg DE, Howe MM, eds. Mobile DNA.Washington, DC: American Society for Microbiology; 1989:269-288.
44. Lindsay JA, Moore CE, Day NP, et al. Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J Bacteriol. 2006;188 (2):669-676.